您当前的位置:
首页 >
文章列表页 >
TCM Treatment of Sarcopenia Based on PI3K/Akt Signaling Pathway: A Review
更新时间:2026-02-28
    • TCM Treatment of Sarcopenia Based on PI3K/Akt Signaling Pathway: A Review

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 6, Pages: 316-326(2026)
    • DOI:10.13422/j.cnki.syfjx.20251492    

      CLC: R242;R255.6;R746.4
    • Received:19 November 2024

      Revised:2025-03-04

      Accepted:02 April 2025

      Online First:21 April 2025

      Published:20 March 2026

    移动端阅览

  • CHEN Yan,DAI Ting,GUO Changsheng,et al.TCM Treatment of Sarcopenia Based on PI3K/Akt Signaling Pathway: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(06):316-326. DOI: 10.13422/j.cnki.syfjx.20251492.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

182

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Xiaochuanning Granules in Treatment of Bronchial Asthma via PI3K/Akt Signaling Pathway Based on Network Pharmacology and Experimental Verification

Related Author

HUANG Shuai-yang
HOU Dan
HUANG Gui-rui
LYU Ming-sheng
GONG Xue-feng
ZHANG Shi-yu
ZHANG Zhi-jie
CUI Hong-sheng

Related Institution

Beijing University of Chinese Medicine Third Affiliated Hospital
Beijing University of Chinese Medicine
Beijing Chaoyang Hospital,Capital Medical University
0